Dr. Patricia Maynard, PSYD. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 55 Main St Ste 312, Newmarket, NH 03857 Phone: 978-223-0277 |
Dr. Sandra K Vallery, PH.D Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 8 Kielty Dr, Newmarket, NH 03857 Phone: 603-772-4644 Fax: 603-772-4610 |
News Archive
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration has approved Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.
Hundreds of parents whose children with autism have been abandoned by the Ontario government announced today at Queen's Park that they are intensifying their efforts to make autism therapy more accessible by training in civil disobedience, peaceful protest and other more assertive forms of advocacy.
Karim Kader, MD, PhD, associate clinical professor at the UC San Diego School of Medicine, together with a team of researchers from Wake Forest University School of Medicine, have developed a genetic test to predict a man's risk for prostate cancer. Use of the test could reduce the need for repeat biopsies in men who have had a negative biopsy.
Metabolomics is a post-genomic research field for analysis of low molecular weight compounds in biological systems, and its approaches offer an analysis of metabolite level changes in biological samples. Recently, metabolomic method has shown great potentials in identifying the new diagnostic markers and therapeutic targets for cancers. However, metabolomic studies on cancer metastasis remain scarce.
› Verified 3 days ago